Personalized Group Cognitive Behavioural Therapy for Obesity: a Longitudinal Study in a Real-world Clinical Setting
Overview
Authors
Affiliations
Purpose: Severe obesity is difficult to treat, and non-surgical treatment is not supported by robust evidence. The aim of the present study was to establish the immediate and longer-term outcomes following "personalized" form of group cognitive behavioural therapy for obesity (CBT-OB)-a new treatment designed to address specific cognitive processes that have been associated with attrition, weight loss, and weight maintenance in previous studies.
Methods: Sixty-seven adult patients with obesity (body mass index (BMI) ≥ 30 kg/m) were recruited from consecutive referrals to an Italian National Health Service obesity clinic. Each patient was offered 22 group sessions of CBT-OB (14 in the 6-month weight-loss phase and 8 in the subsequent 12-month weight-maintenance phase).
Results: 76.2% patients completed the treatment, with an average weight loss of 11.5% after 6 months (10% in the intention-to-treat analysis) and 9.9% (7.5% in the intention-to-treat analysis) after 18 months. Weight loss was associated with a significant reduction in cardiovascular risk factors, anxiety, depression, and eating disorder psychopathology, and an improvement in obesity-related quality of life.
Conclusions: These findings provide strong preliminary support for the use of CBT-OB for obesity in standard clinical settings, and justify its further evaluation in randomized controlled trials.
Level Of Evidence: Level III, longitudinal cohort study.
Tsompanaki E, Koutoukidis D, Wren G, Tong H, Theodoulou A, Wang D EClinicalMedicine. 2025; 80:103049.
PMID: 39981343 PMC: 11841075. DOI: 10.1016/j.eclinm.2024.103049.
Weight Loss Programs: Why Do They Fail? A Multidimensional Approach for Obesity Management.
Khattab R Curr Nutr Rep. 2024; 13(3):478-499.
PMID: 38861120 DOI: 10.1007/s13668-024-00551-x.
Lopes Neri L, Mariotti F, Guglielmetti M, Fiorini S, Tagliabue A, Ferraris C Front Nutr. 2024; 11:1250683.
PMID: 38784136 PMC: 11111870. DOI: 10.3389/fnut.2024.1250683.
Kurnik Mesaric K, Kodric J, Zakrajsek B, Marn Pernat A, Bogataj S, Pajek J Contemp Clin Trials Commun. 2023; 36:101236.
PMID: 38074489 PMC: 10709099. DOI: 10.1016/j.conctc.2023.101236.
Applying psycho-behavioural phenotyping in obesity characterization.
Camacho-Barcia L, Lucas I, Miranda-Olivos R, Jimenez-Murcia S, Fernandez-Aranda F Rev Endocr Metab Disord. 2023; 24(5):871-883.
PMID: 37261609 PMC: 10492697. DOI: 10.1007/s11154-023-09810-8.